has been cited by the following article(s):
[1]
|
A randomized clinical trial of Premaquick biomarkers versus transvaginal cervical length for pre-induction cervical assessment at term among pregnant women
SAGE Open Medicine,
2023
DOI:10.1177/20503121231158220
|
|
|
[2]
|
Benefits of Premaquick® Combined Detection of IL-6/Total IGFBP-1/Native IGFBP-1 to Predict Preterm Delivery
Journal of Clinical Medicine,
2023
DOI:10.3390/jcm12175707
|
|
|
[3]
|
Combined insulin‐like growth factor binding protein‐1/interleukin‐6 (Premaquick) versus fetal fibronectin for predicting preterm delivery among women with preterm contractions
International Journal of Gynecology & Obstetrics,
2020
DOI:10.1002/ijgo.13128
|
|
|
[4]
|
Insulin-like growth factor binding protein-1 predicts preterm premature rupture of membranes in twin pregnancies
Archives of Gynecology and Obstetrics,
2019
DOI:10.1007/s00404-019-05214-9
|
|
|